Publicações

Management of Adverse Events in Patients with Acute Myeloid Leukemia in Remission Receiving Oral Azacitidine: Experience from the Phase 3 Randomized Quazar Aml-001 Trial

AuthID
P-00V-ASC

Author(s)

Ravandi, F

Roboz, GJ

Wei, AH

Dohner, H

Pocock, C

Selleslag, D

Montesinos, P

Sayar, H

Musso, M

Figuera Alvarez, A

[+2]·

Sohn, SK

Hiwase, D

Chevassut, T

Pierdomenico, F

La Torre, I

Skikne, B

Bailey, R

Zhong, JH

Beach, CL

Dombret, H

View all authors

Document Type

Article

Year published

2021

Published

in JOURNAL OF HEMATOLOGY & ONCOLOGY, ISSN: 1756-8722

Volume: 14, Issue: 1

Indexing

Wos^®

Scopus^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1186/s13045-021-01142-x

Scopus: 2-s2.0-85113742847

Wos: WOS:000690958700002

Source Identifiers

ISSN: 1756-8722

Export Publication Metadata

Lista Marked

Adicionar à lista Marked

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Nome	Name Order	Nome	Name Order	Nome
1	Ravandi, F;	2	Roboz, GJ;	3	Wei, AH;
4	Dohner, H;	5	Pocock, C;	6	Selleslag, D;
7	Montesinos, P;	8	Sayar, H;	9	Musso, M;
10	Figuera Alvarez, A;	11	Safah, H;	12	Tse, W;
13	Sohn, SK;	14	Hiwase, D;	15	Chevassut, T;
16	Pierdomenico, F;	17	La Torre, I;	18	Skikne, B;
19	Bailey, R;	20	Zhong, JH;	21	Beach, CL;
22	Dombret, H;

Management of Adverse Events in Patients with Acute Myeloid Leukemia in Remission Receiving Oral Azacitidine: Experience from the Phase 3 Randomized Quazar Aml-001 Trial

Useful Links

Get Help

Autenticação Federada (Click on the image)

Management of Adverse Events in Patients with Acute Myeloid Leukemia in Remission Receiving Oral Azacitidine: Experience from the Phase 3 Randomized Quazar Aml-001 Trial

Useful Links

Get Help